News summaryInvesting.comOct 29, 2026, 05:12 PM
Brookline Capital raises Kymera Therapeutics price target on reduced risk
KYMRpharmaceuticals
Brookline Capital raises Kymera Therapeutics price target on reduced risk(摘要待生成)
Loading...
Brookline Capital raises Kymera Therapeutics price target on reduced risk(摘要待生成)